The store will not work correctly when cookies are disabled.
4-Acetamido-5-butyramido-2-fluoro benzoic acid
ID: ALA558122
PubChem CID: 45273498
Max Phase: Preclinical
Molecular Formula: C13H15FN2O4
Molecular Weight: 282.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCC(=O)Nc1cc(C(=O)O)c(F)cc1NC(C)=O
Standard InChI: InChI=1S/C13H15FN2O4/c1-3-4-12(18)16-10-5-8(13(19)20)9(14)6-11(10)15-7(2)17/h5-6H,3-4H2,1-2H3,(H,15,17)(H,16,18)(H,19,20)
Standard InChI Key: FSNZWXMHZZAIPE-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
-0.6437 -2.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0707 -3.2219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7852 -2.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7852 -1.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0707 -1.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6437 -1.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3582 -1.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0727 -1.9844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3582 -0.7469 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3582 -3.2219 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.4997 -3.2219 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4997 -4.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2141 -4.4594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7852 -4.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4997 -1.5719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2141 -1.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2141 -2.8094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9286 -1.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6431 -1.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6431 -2.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0
2 3 1 0
3 11 1 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
12 14 1 0
6 7 1 0
4 15 1 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
16 18 1 0
7 9 2 0
18 19 1 0
4 5 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.27 | Molecular Weight (Monoisotopic): 282.1016 | AlogP: 2.22 | #Rotatable Bonds: 5 |
Polar Surface Area: 95.50 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.25 | CX Basic pKa: ┄ | CX LogP: 1.39 | CX LogD: -2.04 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -1.24 |
References
1. Magesh S, Savita V, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M.. (2009) Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids., 17 (13): [PMID:19450982] [10.1016/j.bmc.2009.04.065] |